Carbon Brand Solutions

Emerging Therapeutic Proteins in Type 2 Diabetes Management : Forty-two genes were identified as associated with type 2 diabetes mellitus, with five (CLSTN1, KCNJ11, MLX, RELA, and ULK1) showing strong therapeutic potential. These were validated through genetic analysis, protein expression studies, and drug-target prediction methods. Their distinct biological roles in metabolism, insulin secretion, inflammation, and autophagy highlight them as promising drug targets. Read more: https://lnkd.in/dSZ36Wvi #diabetesmanagement #type2 #type2diabetesmanagement #diabetesstudy #diabetesresearch #type2management #medicalupdate #medicalupdates #medicalnews #newmedicalstudy #newhealthcarestudy #newmedicalresearch #medicalresearch #pharmaupdate #pharmaupdates #pharmanews #pharmaresearch #hcp #healthcare #healthcareprofessional #healthcareprofessionals #healthcareupdate #healthcareupdates #healthcarenews #healthcareresearch #scientificupdate #carbonbrandsolutions

Distribution and Usage Trends of SGLT2 Inhibitors and Sacubitril/Valsartan in Underserved Cardiac Care : A Kansas City safety net hospital study found that non-cardiologist providers, including nurse practitioners and primary care physicians, play a major role in prescribing sacubitril/valsartan and SGLT2 inhibitors to underserved heart failure patients. Access programs and 340B pricing improved medication availability, supporting wider use across specialties. The shift toward a multidisciplinary care model reflects evolving heart failure management and improved treatment equity. Read more: https://lnkd.in/daR59jsB #medicalupdate #medicalupdates #medicalnews #newmedicalstudy #newhealthcarestudy #newmedicalresearch #medicalresearch #pharmaupdate #pharmaupdates #pharmanews #pharmaresearch #hcp #healthcare #healthcareprofessional #healthcareprofessionals #healthcareupdate #healthcareupdates #healthcarenews #healthcareresearch #scientificupdate #carbonbrandsolutions

Heart Failure: Integrative Management with Lifestyle and Pharmacology - To effectively manage heart failure, combining medications with lifestyle changes like diet, exercise, and stress management is crucial. This comprehensive approach improves patient outcomes, reduces hospitalizations, and enhances the effectiveness of drug therapies. Overcoming barriers like socioeconomic challenges and ensuring patient education are essential for successful implementation. Read more: https://lnkd.in/dGyjvJSj #hypertension #hypertensioncare #cardiology #cardiologist #medicalupdate #medicalupdates #medicalnews #newmedicalstudy #newhealthcarestudy #newmedicalresearch #medicalresearch #pharmaupdate #pharmaupdates #pharmanews #pharmaresearch #hcp #healthcare #healthcareprofessional #healthcareprofessionals #healthcareupdate #healthcareupdates #healthcarenews #healthcareresearch #scientificupdate #carbonbrandsolutions

Optimizing Hypertension Care Through Preexisting Cardiovascular Insights : The study examines how different treatments and factors impact heart health, following patients over time to assess effectiveness and risks. It highlights the need for personalized care, as some treatments work better than others and may require adjustments to medical guidelines. The findings help doctors improve heart disease management and pave the way for safer, more effective treatments. Read more: https://lnkd.in/dNi7CdcH #hypertension #hypertensioncare #cardiology #cardiologist #medicalupdate #medicalupdates #medicalnews #newmedicalstudy #newhealthcarestudy #newmedicalresearch #medicalresearch #pharmaupdate #pharmaupdates #pharmanews #pharmaresearch #hcp #healthcare #healthcareprofessional #healthcareprofessionals #healthcareupdate #healthcareupdates #healthcarenews #healthcareresearch #scientificupdate #carbonbrandsolutions

New Study: Oral Semaglutide Protects Heart in Diabetes Patients - A new study shows that oral semaglutide lowers the risk of heart attacks and strokes by 14% in people with type 2 diabetes and cardiovascular disease. The trial, involving 9,650 participants, found its effects similar to the injectable version of the drug. Researchers say this oral option is a major advancement in diabetes care, though more studies are needed. Read more: https://lnkd.in/dFsk9wH5 #semaglutide #diabetesmanagement #type2diabetesmanagement #type2 #type2diabetes #medicalupdate #medicalupdates #medicalnews #newmedicalstudy #newhealthcarestudy #newmedicalresearch #medicalresearch #pharmaupdate #pharmaupdates #pharmanews #pharmaresearch #hcp #healthcare #healthcareprofessional #healthcareprofessionals #healthcareupdate #healthcareupdates #healthcarenews #healthcareresearch #scientificupdate #carbonbrandsolutions

Fendo is a pain-relieving medicine containing Diclofenac Sodium, which reduces inflammation and swelling. It helps with conditions like arthritis, muscle pain, and post-surgical discomfort, providing quick relief in tablet, gel, or injection form. While effective, it should be taken under medical supervision to avoid side effects, especially for those with heart, kidney, or liver issues. Read more: https://lnkd.in/dCKw-qWv #medicalupdate #medicalupdates #medicalnews #medicalresearch #pharmaupdate #pharmaupdates #pharmanews #pharmaresearch #hcp #healthcare #healthcareprofessional #healthcareprofessionals #healthcareupdate #healthcareupdates #healthcarenews #healthcareresearch #scientificupdate #carbonbrandsolutions

Breakthrough: FDA Greenlights Drug for Prader-Willi Hunger Control - The FDA has approved Vykat XR, the first drug to treat hyperphagia in Prader-Willi syndrome, a rare genetic disorder causing extreme, persistent hunger. Clinical trials showed it significantly reduced hunger-related symptoms, offering a new alternative to strict dieting. Expected to launch in April, Vykat XR could greatly improve life for patients and their families. Read more: https://lnkd.in/dE_zfMYv #vykatxr #hyperphagia #fdapproved #medicalupdate #medicalupdates #medicalnews #medicalresearch #pharmaupdate #pharmaupdates #pharmanews #pharmaresearch #hcp #healthcare #healthcareprofessional #healthcareprofessionals #healthcareupdate #healthcareupdates #healthcarenews #healthcareresearch #scientificupdate #carbonbrandsolutions

NPAR as a Predictor of Mortality in Diabetes and Prediabetes : This study found that the Neutrophil Percentage-to-Albumin Ratio (NPAR) is a strong predictor of mortality in people with diabetes or prediabetes. Higher NPAR levels were linked to an increased risk of death, especially when exceeding 15.1 for all-cause mortality and 14.2 for cardiovascular mortality. As a simple and cost-effective blood test, NPAR could help doctors identify high-risk patients early and take preventive measures. Read more: https://lnkd.in/dFv5iwTy #diabetoology #diabetlogist #diabetologists #cardiology #newdiagnostic #newdiagnostics #medicalupdate #medicalupdates #medicalnews #medicalresearch #pharmaupdate #pharmaupdates #pharmanews #pharmaresearch #hcp #healthcare #healthcareprofessional #healthcareprofessionals #healthcareupdate #healthcareupdates #healthcarenews #healthcareresearch #scientificupdate #newhealthcareupdate #newhealthcareupdates #carbonbrandsolutions

Hidden Danger: How a Rare Heart Cancer Led to Life-Threatening Arrhythmia - A 67-year-old man presenting with recurrent syncope was diagnosed with Primary Cardiac Lymphoma, a very rare cardiac malignancy resulting in cardiac obstruction and accumulation of fluid. Further diagnostic imaging tests and lymph node biopsy confirmed the diagnosis of aggressive Diffuse Large B-Cell Lymphoma. The patient was treated with chemotherapy and pacemaker placement, and this brought about remarkable recovery of cardiac function and overall well-being. Read more: https://lnkd.in/dbNHgw79 #cardiology #cardiologist #cardiologists #heartcancer #lympphoma #newdiagnostic #newdiagnostics #arrhythmia #medicalupdate #medicalupdates #medicalnews #medicalresearch #pharmaupdate #pharmaupdates #pharmanews #pharmaresearch #hcp #healthcare #healthcareprofessional #healthcareprofessionals #healthcareupdate #healthcareupdates #healthcarenews #healthcareresearch #scientificupdate #newhealthcareupdate #newhealthcareupdates #carbonbrandsolutions

Turn heads in clinics! Pull Push combines motion with messaging to create unforgettable brand interactions. DM us or Contact us @ carbongroup.in for your any healthcare communication requirement ! #pharmaadvertising #pharmaadvertisingagency #healthcarecommunication #healthcarecommunicationagency #medicomarketing #medicomarketingagency #pharmabrand #pharmabrandplanning #pharmabrandrequirment #healthcare #hcp #pharma #pharmaceutical #healthcaremarketing #healthcareadvertising #carbonbrandsolutions